Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342091 · ClinicalTrials.gov registry record · NA
Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04342091 is a NA study that has completed, run by Yale University. The registered enrollment target is 6 participants.
The verdict
NCT04342091, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
To evaluate the efficacy microneedling via a professional tattoo machine in revitalizing hair follicles in patients with fibrosing alopecia.
Interventions
- DEVICE SOL Nova Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2022-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04342091
The ClinicalTrials.gov registry entry for NCT04342091 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SOL Nova Device is the first listed.
NCT04342091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04342091 about?
NCT04342091 is a clinical study titled "Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling". To evaluate the efficacy microneedling via a professional tattoo machine in revitalizing hair follicles in patients with fibrosing alopecia.
What is the current status of trial NCT04342091?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-04-09. Estimated completion is 2022-04-08.
What interventions are being tested in trial NCT04342091?
The interventions under investigation include: SOL Nova Device (DEVICE).
Who is sponsoring clinical trial NCT04342091?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.